Works matching IS 00070920 AND DT 2016 AND VI 115 AND IP 10

Results: 17

Projected cancer risks potentially related to past, current, and future practices in paediatric CT in the United Kingdom, 1990-2020.

Published in:

2016

By:

Journy, Neige M Y;
Lee, Choonsik;
Harbron, Richard W;
McHugh, Kieran;
Pearce, Mark S;
Berrington de González, Amy

Publication type:

journal article

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

Published in:

2016

By:

Ledermann, Jonathan A;
Harter, Philipp;
Gourley, Charlie;
Friedlander, Michael;
Vergote, Ignace;
Rustin, Gordon;
Scott, Clare;
Meier, Werner;
Shapira-Frommer, Ronnie;
Safra, Tamar;
Matei, Daniela;
Fielding, Anitra;
Bennett, Bryan;
Parry, David;
Spencer, Stuart;
Mann, Helen;
Matulonis, Ursula

Publication type:

journal article

Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.

Published in:

2016

By:

Ouldamer, Lobna;
Bendifallah, Sofiane;
Body, Gilles;
Touboul, Cyril;
Graesslin, Olivier;
Raimond, Emilie;
Collinet, Pierre;
Coutant, Charles;
Lavoué, Vincent;
Lévêque, Jean;
Daraï, Emile;
Ballester, Marcos

Publication type:

journal article

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.

Published in:

2016

By:

MacLeod, A Kenneth;
Acosta-Jimenez, Lourdes;
Coates, Philip J;
McMahon, Michael;
Carey, Frank A;
Honda, Tadashi;
Henderson, Colin J;
Wolf, C Roland

Publication type:

journal article

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

Published in:

2016

By:

Prochazka, Katharina T;
Melchardt, Thomas;
Posch, Florian;
Schlick, Konstantin;
Deutsch, Alexander;
Beham-Schmid, Christine;
Weiss, Lukas;
Gary, Thomas;
Neureiter, Daniel;
Klieser, Eckhard;
Greil, Richard;
Neumeister, Peter;
Egle, Alexander;
Pichler, Martin

Publication type:

journal article

DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.

Published in:

2016

By:

Drouillard, A;
Puleo, F;
Bachet, J B;
Ouazzani, S;
Calomme, A;
Demetter, P;
Verset, G;
Van Laethem, J L;
Maréchal, R;
Maréchal, R

Publication type:

journal article

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.

Published in:

2016

By:

Karthaus, Meinolf;
Hofheinz, Ralf-Dieter;
Mineur, Laurent;
Letocha, Henry;
Greil, Richard;
Thaler, Josef;
Fernebro, Eva;
Oliner, Kelly S;
Boedigheimer, Michael;
Twomey, Brian;
Zhang, Ying;
Demonty, Gaston;
Köhne, Claus-Henning;
Köhne, Claus-Henning

Publication type:

journal article

Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.

Published in:

2016

By:

Ou, Wen-Bin;
Lu, Minmin;
Eilers, Grant;
Li, Hailong;
Ding, Jiongyan;
Meng, Xuli;
Wu, Yuehong;
He, Quan;
Sheng, Qing;
Zhou, Hai-Meng;
Fletcher, Jonathan A

Publication type:

journal article

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.

Published in:

2016

By:

Blinman, Prunella;
Mileshkin, Linda;
Khaw, Pearly;
Goss, Geraldine;
Johnson, Carol;
Capp, Anne;
Brooks, Susan;
Wain, Gerard;
Kolodziej, Ilka;
Veillard, Anne-Sophie;
O'Connell, Rachel;
Creutzberg, Carien L;
Stockler, Martin R;
ANZGOG and PORTEC Group

Publication type:

journal article

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer.

Published in:

2016

By:

Kim, Tae Won;
Elme, Anneli;
Kusic, Zvonko;
Park, Joon Oh;
Udrea, Anghel Adrian;
Kim, Sun Young;
Ahn, Joong Bae;
Valencia, Ricardo Villalobos;
Krishnan, Srinivasan;
Bilic, Ante;
Manojlovic, Nebojsa;
Dong, Jun;
Guan, Xuesong;
Lofton-Day, Catherine;
Jung, A Scott;
Vrdoljak, Eduard

Publication type:

journal article

TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials.

Published in:

2016

By:

Lee, Dae-Won;
Jang, Myoung-Jin;
Lee, Kyung-Hun;
Cho, Eun Ju;
Lee, Jeong-Hoon;
Yu, Su Jong;
Kim, Yoon Jun;
Yoon, Jung-Hwan;
Kim, Tae-Yong;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You

Publication type:

journal article

PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.

Published in:

2016

By:

Konecny, G E;
Kristeleit, R S

Publication type:

journal article

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients.

Published in:

2016

By:

Khoja, Leila;
Kibiro, Minnie;
Metser, Ur;
Gedye, Craig;
Hogg, David;
Butler, Marcus O;
Atenafu, Eshetu G;
Joshua, Anthony M

Publication type:

journal article

IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.

Published in:

2016

By:

Matsuoka, Yuichiro;
Nakayama, Hideki;
Yoshida, Ryoji;
Hirosue, Akiyuki;
Nagata, Masashi;
Tanaka, Takuya;
Kawahara, Kenta;
Sakata, Junki;
Arita, Hidetaka;
Nakashima, Hikaru;
Shinriki, Satoru;
Fukuma, Daiki;
Ogi, Hidenao;
Hiraki, Akimitsu;
Shinohara, Masanori;
Toya, Ryo;
Murakami, Ryuji

Publication type:

journal article

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

Published in:

2016

By:

Zaaijer, Leendert H;
van Doorn, Helena C;
Mourits, Marian J E;
van Beurden, Marc;
de Hullu, Joanne A;
Adank, Muriel A;
van Lonkhuijzen, Luc R C W;
Vasen, Hans F A;
Slangen, Brigitte F M;
Gaarenstroom, Katja N;
Zweemer, Ronald P;
Vencken, Peggy M L H;
Seynaeve, Caroline;
Kriege, Mieke

Publication type:

journal article

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

Published in:

2016

By:

Gupta, Avinash;
Roberts, Corran;
Tysoe, Finn;
Goff, Matthew;
Nobes, Jenny;
Lester, James;
Marshall, Ernie;
Corner, Carie;
Wolstenholme, Virginia;
Kelly, Charles;
Wise, Adelyn;
Collins, Linda;
Love, Sharon;
Woodward, Martha;
Salisbury, Amanda;
Middleton, Mark R

Publication type:

journal article

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.

Published in:

2016

By:

Marzi, L;
Combes, E;
Vié, N;
Ayrolles-Torro, A;
Tosi, D;
Desigaud, D;
Perez-Gracia, E;
Larbouret, C;
Montagut, C;
Iglesias, M;
Jarlier, M;
Denis, V;
Linares, L K;
Lam, E W-F;
Martineau, P;
Del Rio, M;
Gongora, C;
Vié, N

Publication type:

journal article